cid,Gene,Gene_Name,Protein ID,Protein_Name,mode,action,a_is_acting,score,drug_name
CID000077992,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,activation,activation,t,991,158747-02-5
CID000077992,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,958,158747-02-5
CID000002083,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,958,(Â±)-Albuterol
CID000002088,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,inhibition,inhibition,t,987,alendronic acid
CID000004932,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,999,54063-53-5
CID000004932,6331,SCN5A,9606.ENSP00000328968,Sodium channel protein type 5 subunit alpha,inhibition,inhibition,t,991,54063-53-5
CID000000271,108,ADCY2,9606.ENSP00000342952,Adenylate cyclase type 2,binding,activation,t,899,Calcium(II) ion
CID000000271,108,ADCY2,9606.ENSP00000342952,Adenylate cyclase type 2,binding,activation,t,900,Calcium(II) ion
CID000000271,107,ADCY1,9606.ENSP00000297323,Adenylate cyclase type 1,binding,activation,t,899,Calcium(II) ion
CID000000271,107,ADCY1,9606.ENSP00000297323,Adenylate cyclase type 1,binding,activation,t,900,Calcium(II) ion
CID000000271,5532,PPP3CB,9606.ENSP00000378306,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,activation,activation,t,999,Calcium(II) ion
CID000000271,5530,PPP3CA,9606.ENSP00000378323,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,activation,activation,t,999,Calcium(II) ion
CID000000271,5879,RAC1,9606.ENSP00000348461,Ras-related C3 botulinum toxin substrate 1,activation,activation,t,899,Calcium(II) ion
CID000000271,5879,RAC1,9606.ENSP00000348461,Ras-related C3 botulinum toxin substrate 1,activation,activation,t,900,Calcium(II) ion
CID000000271,3816,KLK1,9606.ENSP00000301420,Kallikrein-1,inhibition,inhibition,t,700,Calcium(II) ion
CID000000271,3781,KCNN2,9606.ENSP00000264773,Small conductance calcium-activated potassium channel protein 2,activation,activation,t,700,Calcium(II) ion
CID000000271,814,CAMK4,9606.ENSP00000282356,Calcium/calmodulin-dependent protein kinase type IV,activation,activation,t,989,Calcium(II) ion
CID000000271,2986,GUCY2F,9606.ENSP00000218006,Retinal guanylyl cyclase 2,binding,inhibition,t,989,Calcium(II) ion
CID000000271,3066,HDAC2,9606.ENSP00000430432,Histone deacetylase 2,activation,activation,t,899,Calcium(II) ion
CID000000271,3066,HDAC2,9606.ENSP00000430432,Histone deacetylase 2,activation,activation,t,900,Calcium(II) ion
CID000000271,2157,F8,9606.ENSP00000353393,"Factor VIIIa heavy chain, 200 kDa isoform",activation,activation,t,989,Calcium(II) ion
CID000000271,2153,F5,9606.ENSP00000356771,Coagulation factor V heavy chain,activation,activation,t,899,Calcium(II) ion
CID000000271,2153,F5,9606.ENSP00000356771,Coagulation factor V heavy chain,activation,activation,t,900,Calcium(II) ion
CID000000271,2158,F9,9606.ENSP00000218099,Coagulation factor IXa heavy chain,activation,activation,t,999,Calcium(II) ion
CID000000271,2159,F10,9606.ENSP00000364709,Activated factor Xa heavy chain,activation,activation,t,989,Calcium(II) ion
CID000000271,824,CAPN2,9606.ENSP00000295006,Calpain-2 catalytic subunit,activation,activation,t,900,Calcium(II) ion
CID000000271,824,CAPN2,9606.ENSP00000295006,Calpain-2 catalytic subunit,activation,activation,t,899,Calcium(II) ion
CID000000271,2098,ESD,9606.ENSP00000367992,S-formylglutathione hydrolase,binding,inhibition,t,899,Calcium(II) ion
CID000000271,2098,ESD,9606.ENSP00000367992,S-formylglutathione hydrolase,binding,inhibition,t,900,Calcium(II) ion
CID000000271,2147,F2,9606.ENSP00000308541,Activation peptide fragment 1,activation,activation,t,980,Calcium(II) ion
CID000000271,2147,F2,9606.ENSP00000308541,Activation peptide fragment 1,activation,activation,t,900,Calcium(II) ion
CID000000271,2934,GSN,9606.ENSP00000362924,Gelsolin,activation,activation,t,800,Calcium(II) ion
CID000000271,3000,GUCY2D,9606.ENSP00000254854,Retinal guanylyl cyclase 1,binding,inhibition,t,989,Calcium(II) ion
CID000000271,4153,MBL2,9606.ENSP00000363079,Mannose-binding protein C,activation,activation,t,900,Calcium(II) ion
CID000000271,4153,MBL2,9606.ENSP00000363079,Mannose-binding protein C,activation,activation,t,899,Calcium(II) ion
CID000000271,30818,KCNIP3,9606.ENSP00000295225,Calsenilin,activation,activation,t,899,Calcium(II) ion
CID000000271,30818,KCNIP3,9606.ENSP00000295225,Calsenilin,activation,activation,t,900,Calcium(II) ion
CID000000271,6469,SHH,9606.ENSP00000297261,Sonic hedgehog protein N-product,activation,activation,t,957,Calcium(II) ion
CID000000271,2160,F11,9606.ENSP00000384957,Coagulation factor XIa heavy chain,activation,activation,t,900,Calcium(II) ion
CID000000271,2160,F11,9606.ENSP00000384957,Coagulation factor XIa heavy chain,activation,activation,t,899,Calcium(II) ion
CID000000271,5582,PRKCG,9606.ENSP00000263431,Protein kinase C gamma type,activation,activation,t,900,Calcium(II) ion
CID000000271,5582,PRKCG,9606.ENSP00000263431,Protein kinase C gamma type,activation,activation,t,899,Calcium(II) ion
CID000000271,5583,PRKCH,9606.ENSP00000329127,Protein kinase C eta type,activation,activation,t,900,Calcium(II) ion
CID000000271,5583,PRKCH,9606.ENSP00000329127,Protein kinase C eta type,activation,activation,t,899,Calcium(II) ion
CID000000271,5580,PRKCD,9606.ENSP00000331602,Protein kinase C delta type regulatory subunit,activation,activation,t,900,Calcium(II) ion
CID000000271,5580,PRKCD,9606.ENSP00000331602,Protein kinase C delta type regulatory subunit,activation,activation,t,899,Calcium(II) ion
CID000000271,5581,PRKCE,9606.ENSP00000306124,Protein kinase C epsilon type,activation,activation,t,899,Calcium(II) ion
CID000000271,5581,PRKCE,9606.ENSP00000306124,Protein kinase C epsilon type,activation,activation,t,900,Calcium(II) ion
CID000000271,5588,PRKCQ,9606.ENSP00000263125,Protein kinase C theta type,activation,activation,t,900,Calcium(II) ion
CID000000271,5588,PRKCQ,9606.ENSP00000263125,Protein kinase C theta type,activation,activation,t,899,Calcium(II) ion
CID000000271,140838,NANP,9606.ENSP00000302441,N-acylneuraminate-9-phosphatase,binding,inhibition,t,899,Calcium(II) ion
CID000000271,140838,NANP,9606.ENSP00000302441,N-acylneuraminate-9-phosphatase,binding,inhibition,t,900,Calcium(II) ion
CID000000271,2978,GUCA1A,9606.ENSP00000053469,Guanylyl cyclase-activating protein 1,activation,activation,t,900,Calcium(II) ion
CID000000271,2978,GUCA1A,9606.ENSP00000053469,Guanylyl cyclase-activating protein 1,activation,activation,t,899,Calcium(II) ion
CID000000271,5578,PRKCA,9606.ENSP00000408695,Protein kinase C alpha type,activation,activation,t,999,Calcium(II) ion
CID000000271,5568,PRKACG,9606.ENSP00000366488,cAMP-dependent protein kinase catalytic subunit gamma,activation,activation,t,899,Calcium(II) ion
CID000000271,5568,PRKACG,9606.ENSP00000366488,cAMP-dependent protein kinase catalytic subunit gamma,activation,activation,t,900,Calcium(II) ion
CID000000271,5567,PRKACB,9606.ENSP00000359719,cAMP-dependent protein kinase catalytic subunit beta,activation,activation,t,899,Calcium(II) ion
CID000000271,5567,PRKACB,9606.ENSP00000359719,cAMP-dependent protein kinase catalytic subunit beta,activation,activation,t,900,Calcium(II) ion
CID000000271,1259,CNGA1,9606.ENSP00000384264,cGMP-gated cation channel alpha-1,activation,activation,t,899,Calcium(II) ion
CID000000271,1259,CNGA1,9606.ENSP00000384264,cGMP-gated cation channel alpha-1,activation,activation,t,900,Calcium(II) ion
CID000000271,713,C1QB,9606.ENSP00000313967,Complement C1q subcomponent subunit B,activation,activation,t,900,Calcium(II) ion
CID000000271,713,C1QB,9606.ENSP00000313967,Complement C1q subcomponent subunit B,activation,activation,t,899,Calcium(II) ion
CID000000271,712,C1QA,9606.ENSP00000363773,Complement C1q subcomponent subunit A,activation,activation,t,900,Calcium(II) ion
CID000000271,712,C1QA,9606.ENSP00000363773,Complement C1q subcomponent subunit A,activation,activation,t,899,Calcium(II) ion
CID000000271,7125,TNNC2,9606.ENSP00000361636,"Troponin C, skeletal muscle",activation,activation,t,800,Calcium(II) ion
CID000000271,5577,PRKAR2B,9606.ENSP00000265717,cAMP-dependent protein kinase type II-beta regulatory subunit,activation,activation,t,900,Calcium(II) ion
CID000000271,5577,PRKAR2B,9606.ENSP00000265717,cAMP-dependent protein kinase type II-beta regulatory subunit,activation,activation,t,899,Calcium(II) ion
CID000000271,5576,PRKAR2A,9606.ENSP00000265563,cAMP-dependent protein kinase type II-alpha regulatory subunit,activation,activation,t,900,Calcium(II) ion
CID000000271,5576,PRKAR2A,9606.ENSP00000265563,cAMP-dependent protein kinase type II-alpha regulatory subunit,activation,activation,t,899,Calcium(II) ion
CID000000271,3706,ITPKA,9606.ENSP00000260386,Inositol-trisphosphate 3-kinase A,binding,activation,t,899,Calcium(II) ion
CID000000271,3706,ITPKA,9606.ENSP00000260386,Inositol-trisphosphate 3-kinase A,binding,activation,t,900,Calcium(II) ion
CID000000271,7134,TNNC1,9606.ENSP00000232975,"Troponin C, slow skeletal and cardiac muscles",activation,activation,t,800,Calcium(II) ion
CID000000271,5321,PLA2G4A,9606.ENSP00000356436,Cytosolic phospholipase A2,activation,activation,t,900,Calcium(II) ion
CID000000271,5321,PLA2G4A,9606.ENSP00000356436,Cytosolic phospholipase A2,activation,activation,t,899,Calcium(II) ion
CID000000271,1511,CTSG,9606.ENSP00000216336,Cathepsin G,inhibition,inhibition,t,800,Calcium(II) ion
CID000000271,124583,CANT1,9606.ENSP00000307674,Soluble calcium-activated nucleotidase 1,activation,activation,t,800,Calcium(II) ion
CID000000271,115,ADCY9,9606.ENSP00000294016,Adenylate cyclase type 9,binding,activation,t,900,Calcium(II) ion
CID000000271,115,ADCY9,9606.ENSP00000294016,Adenylate cyclase type 9,binding,activation,t,899,Calcium(II) ion
CID000000271,114,ADCY8,9606.ENSP00000286355,Adenylate cyclase type 8,binding,activation,t,900,Calcium(II) ion
CID000000271,114,ADCY8,9606.ENSP00000286355,Adenylate cyclase type 8,binding,activation,t,899,Calcium(II) ion
CID000000271,111,ADCY5,9606.ENSP00000419361,Adenylate cyclase type 5,inhibition,inhibition,t,700,Calcium(II) ion
CID000000271,111,ADCY5,9606.ENSP00000419361,Adenylate cyclase type 5,binding,activation,t,900,Calcium(II) ion
CID000000271,111,ADCY5,9606.ENSP00000419361,Adenylate cyclase type 5,binding,activation,t,899,Calcium(II) ion
CID000000271,112,ADCY6,9606.ENSP00000311405,Adenylate cyclase type 6,binding,activation,t,899,Calcium(II) ion
CID000000271,112,ADCY6,9606.ENSP00000311405,Adenylate cyclase type 6,binding,activation,t,900,Calcium(II) ion
CID000000271,196883,ADCY4,9606.ENSP00000312126,Adenylate cyclase type 4,binding,activation,t,899,Calcium(II) ion
CID000000271,196883,ADCY4,9606.ENSP00000312126,Adenylate cyclase type 4,binding,activation,t,900,Calcium(II) ion
CID000000271,10423,CDIPT,9606.ENSP00000219789,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,binding,inhibition,t,900,Calcium(II) ion
CID000000271,10423,CDIPT,9606.ENSP00000219789,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,binding,inhibition,t,899,Calcium(II) ion
CID000000271,5330,PLCB2,9606.ENSP00000260402,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",binding,activation,t,900,Calcium(II) ion
CID000000271,5330,PLCB2,9606.ENSP00000260402,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",binding,activation,t,899,Calcium(II) ion
CID000000271,5333,PLCD1,9606.ENSP00000430344,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",activation,activation,t,900,Calcium(II) ion
CID000000271,5333,PLCD1,9606.ENSP00000430344,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",binding,activation,t,900,Calcium(II) ion
CID000000271,5333,PLCD1,9606.ENSP00000430344,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",activation,activation,t,899,Calcium(II) ion
CID000000271,5333,PLCD1,9606.ENSP00000430344,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",binding,activation,t,899,Calcium(II) ion
CID000002267,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,Azelastine
CID000002267,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Azelastine
CID000003961,6915,TBXA2R,9606.ENSP00000393333,Thromboxane A2 receptor,inhibition,inhibition,t,800,114798-26-4
CID000003964,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,Loxapine
CID000003964,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,800,Loxapine
CID000003964,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,958,Loxapine
CID000003964,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,Loxapine
CID000003964,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,Loxapine
CID000003964,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,Loxapine
CID000003964,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,Loxapine
CID000003964,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Loxapine
CID000003964,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Loxapine
CID000003964,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,Loxapine
CID000003964,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Loxapine
CID000003964,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,inhibition,t,800,Loxapine
CID000003964,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,Loxapine
CID000003964,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,Loxapine
CID000003964,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Loxapine
CID000003964,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,800,Loxapine
CID000003964,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,Loxapine
CID000057469,51284,TLR7,9606.ENSP00000370034,Toll-like receptor 7,activation,activation,t,991,99011-02-6
CID000004178,6331,SCN5A,9606.ENSP00000328968,Sodium channel protein type 5 subunit alpha,inhibition,inhibition,t,991,31828-71-4
CID000004178,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,31828-71-4
CID000004171,136,ADORA2B,9606.ENSP00000304501,Adenosine receptor A2b,binding,activation,t,958,Metoprolol
CID000004171,136,ADORA2B,9606.ENSP00000304501,Adenosine receptor A2b,binding,inhibition,t,958,Metoprolol
CID000004171,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,Metoprolol
CID000004171,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,991,Metoprolol
CID000004171,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,Metoprolol
CID000004171,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,999,Metoprolol
CID000004171,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,991,Metoprolol
CID000004171,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Metoprolol
CID000004171,4829,NMBR,9606.ENSP00000258042,Neuromedin-B receptor,binding,activation,t,991,Metoprolol
CID000004171,3361,HTR5A,9606.ENSP00000287907,5-hydroxytryptamine receptor 5A,binding,activation,t,958,Metoprolol
CID000004171,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,binding,activation,t,800,Metoprolol
CID000004171,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,activation,t,800,Metoprolol
CID000004171,2925,GRPR,9606.ENSP00000369643,Gastrin-releasing peptide receptor,binding,activation,t,991,Metoprolol
CID000004171,6752,SSTR2,9606.ENSP00000350198,Somatostatin receptor type 2,binding,activation,t,800,Metoprolol
CID000004171,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Metoprolol
CID000004171,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,Metoprolol
CID000004171,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,activation,t,800,Metoprolol
CID000004171,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,958,Metoprolol
CID000004171,5739,PTGIR,9606.ENSP00000291294,Prostacyclin receptor,binding,activation,t,800,Metoprolol
CID000004171,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,activation,t,800,Metoprolol
CID000004171,11255,HRH3,9606.ENSP00000342560,Histamine H3 receptor,binding,activation,t,800,Metoprolol
CID000001983,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,997,Paracetamol
CID000001983,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,800,Paracetamol
CID000001983,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,999,Paracetamol
CID000001986,768,CA9,9606.ENSP00000367608,Carbonic anhydrase 9,inhibition,inhibition,t,700,acetazolamide
CID000001986,771,CA12,9606.ENSP00000178638,Carbonic anhydrase 12,inhibition,inhibition,t,700,acetazolamide
CID000001986,762,CA4,9606.ENSP00000300900,Carbonic anhydrase 4,inhibition,inhibition,t,991,acetazolamide
CID000001986,760,CA2,9606.ENSP00000285379,Carbonic anhydrase 2,inhibition,inhibition,t,997,acetazolamide
CID000001986,761,CA3,9606.ENSP00000285381,Carbonic anhydrase 3,inhibition,inhibition,t,991,acetazolamide
CID000001986,766,CA7,9606.ENSP00000345659,Carbonic anhydrase 7,inhibition,inhibition,t,991,acetazolamide
CID000002435,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,activation,activation,t,958,Brimonidine
CID000002435,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,activation,t,999,Brimonidine
CID000002435,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,activation,activation,t,991,Brimonidine
CID000002435,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,activation,t,999,Brimonidine
CID000003404,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,991,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime
CID000005291,25,ABL1,9606.ENSP00000361423,Tyrosine-protein kinase ABL1,inhibition,inhibition,t,999,Imatinib
CID000005291,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,998,Imatinib
CID000005291,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,999,Imatinib
CID000005291,6850,SYK,9606.ENSP00000364898,Tyrosine-protein kinase SYK,inhibition,inhibition,t,800,Imatinib
CID000005291,5156,PDGFRA,9606.ENSP00000257290,Platelet-derived growth factor receptor alpha,inhibition,inhibition,t,972,Imatinib
CID000005291,5156,PDGFRA,9606.ENSP00000257290,Platelet-derived growth factor receptor alpha,inhibition,inhibition,t,998,Imatinib
CID000005291,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,activation,activation,t,800,Imatinib
CID000005291,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,999,Imatinib
CID000005291,1436,CSF1R,9606.ENSP00000286301,Macrophage colony-stimulating factor 1 receptor,inhibition,inhibition,t,990,Imatinib
CID000005291,1436,CSF1R,9606.ENSP00000286301,Macrophage colony-stimulating factor 1 receptor,inhibition,inhibition,t,998,Imatinib
CID000005291,5979,RET,9606.ENSP00000347942,Extracellular cell-membrane anchored RET cadherin 120 kDa fragment,inhibition,inhibition,t,957,Imatinib
CID005329102,2322,FLT3,9606.ENSP00000241453,Receptor-type tyrosine-protein kinase FLT3,inhibition,inhibition,t,800,557795-19-4
CID005329102,2321,FLT1,9606.ENSP00000282397,Vascular endothelial growth factor receptor 1,inhibition,inhibition,t,957,557795-19-4
CID005329102,2321,FLT1,9606.ENSP00000282397,Vascular endothelial growth factor receptor 1,inhibition,inhibition,t,991,557795-19-4
CID005329102,2324,FLT4,9606.ENSP00000261937,Vascular endothelial growth factor receptor 3,inhibition,inhibition,t,800,557795-19-4
CID005329102,2324,FLT4,9606.ENSP00000261937,Vascular endothelial growth factor receptor 3,inhibition,inhibition,t,991,557795-19-4
CID005329102,3791,KDR,9606.ENSP00000263923,Vascular endothelial growth factor receptor 2,inhibition,inhibition,t,800,557795-19-4
CID005329102,3791,KDR,9606.ENSP00000263923,Vascular endothelial growth factor receptor 2,inhibition,inhibition,t,998,557795-19-4
CID005329102,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,991,557795-19-4
CID005329102,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,901,557795-19-4
CID005329102,5156,PDGFRA,9606.ENSP00000257290,Platelet-derived growth factor receptor alpha,inhibition,inhibition,t,536,557795-19-4
CID005329102,5156,PDGFRA,9606.ENSP00000257290,Platelet-derived growth factor receptor alpha,inhibition,inhibition,t,991,557795-19-4
CID005329102,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,998,557795-19-4
CID005329102,6197,RPS6KA3,9606.ENSP00000368884,Ribosomal protein S6 kinase alpha-3,inhibition,inhibition,t,700,557795-19-4
CID005329102,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,557795-19-4
CID005329102,6198,RPS6KB1,9606.ENSP00000225577,Ribosomal protein S6 kinase beta-1,inhibition,inhibition,t,800,557795-19-4
CID005329102,1020,CDK5,9606.ENSP00000419782,Cyclin-dependent-like kinase 5,inhibition,inhibition,t,800,557795-19-4
CID005329102,558,AXL,9606.ENSP00000301178,Tyrosine-protein kinase receptor UFO,inhibition,inhibition,t,800,557795-19-4
CID005329102,5292,PIM1,9606.ENSP00000362608,Serine/threonine-protein kinase pim-1,activation,activation,t,957,557795-19-4
CID000002585,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000002585,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,958,Carvedilol
CID000002585,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,700,Carvedilol
CID000002585,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,997,Carvedilol
CID000002585,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000002585,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,binding,inhibition,t,800,Carvedilol
CID000002585,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000002585,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000002585,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000002585,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Carvedilol
CID000002585,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,991,Carvedilol
CID000003715,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,999,indometacin
CID000003715,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,986,indometacin
CID000003715,5468,PPARG,9606.ENSP00000287820,Peroxisome proliferator-activated receptor gamma,activation,activation,t,999,indometacin
CID000003715,3248,HPGD,9606.ENSP00000296522,15-hydroxyprostaglandin dehydrogenase [NAD(+)],activation,activation,t,737,indometacin
CID000003715,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,997,indometacin
CID000003715,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,indometacin
CID000003715,4353,MPO,9606.ENSP00000225275,Myeloperoxidase heavy chain,activation,activation,t,800,indometacin
CID000003715,2739,GLO1,9606.ENSP00000362463,Lactoylglutathione lyase,inhibition,inhibition,t,998,indometacin
CID000003715,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,activation,activation,t,800,indometacin
CID000003715,5732,PTGER2,9606.ENSP00000245457,Prostaglandin E2 receptor EP2 subtype,binding,inhibition,t,800,indometacin
CID000003715,6916,TBXAS1,9606.ENSP00000389414,Thromboxane A synthase 1,inhibition,inhibition,t,800,indometacin
CID000003715,11251,PTGDR2,9606.ENSP00000332812,Prostaglandin D2 receptor 2,binding,activation,t,991,indometacin
CID000003715,11251,PTGDR2,9606.ENSP00000332812,Prostaglandin D2 receptor 2,activation,activation,t,700,indometacin
CID000054454,10599,SLCO1B1,9606.ENSP00000256958,Solute carrier organic anion transporter family member 1B1,inhibition,inhibition,t,700,79902-63-9
CID000054454,3156,HMGCR,9606.ENSP00000287936,3-hydroxy-3-methylglutaryl-coenzyme A reductase,inhibition,inhibition,t,999,79902-63-9
CID000054454,3156,HMGCR,9606.ENSP00000287936,3-hydroxy-3-methylglutaryl-coenzyme A reductase,activation,activation,t,737,79902-63-9
CID000054454,3156,HMGCR,9606.ENSP00000287936,3-hydroxy-3-methylglutaryl-coenzyme A reductase,inhibition,inhibition,t,990,79902-63-9
CID000002160,4985,OPRD1,9606.ENSP00000234961,Delta-type opioid receptor,activation,activation,t,998,50-48-6
CID000002160,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,998,50-48-6
CID000002160,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,50-48-6
CID000002160,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,998,50-48-6
CID000002160,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,50-48-6
CID000002160,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,998,50-48-6
CID000002160,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,50-48-6
CID000002160,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,998,50-48-6
CID000002160,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,50-48-6
CID000002160,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,50-48-6
CID000002160,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,998,50-48-6
CID000002160,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,998,50-48-6
CID000002160,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,inhibition,inhibition,t,998,50-48-6
CID000002160,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,binding,inhibition,t,800,50-48-6
CID000002160,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,998,50-48-6
CID000002160,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,binding,inhibition,t,800,50-48-6
CID000002160,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,50-48-6
CID000002160,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,998,50-48-6
CID000002160,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,50-48-6
CID000002160,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,800,50-48-6
CID000002162,775,CACNA1C,9606.ENSP00000266376,Voltage-dependent L-type calcium channel subunit alpha-1C,inhibition,inhibition,t,800,Amlodipine
CID000002162,775,CACNA1C,9606.ENSP00000266376,Voltage-dependent L-type calcium channel subunit alpha-1C,inhibition,inhibition,t,991,Amlodipine
CID000002162,776,CACNA1D,9606.ENSP00000288139,Voltage-dependent L-type calcium channel subunit alpha-1D,inhibition,inhibition,t,991,Amlodipine
CID000002162,779,CACNA1S,9606.ENSP00000355192,Voltage-dependent L-type calcium channel subunit alpha-1S,inhibition,inhibition,t,991,Amlodipine
CID000002249,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,997,DL-Atenolol
CID000002249,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,800,DL-Atenolol
CID000003410,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,activation,t,800,Formoterol
CID000003410,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,binding,activation,t,800,Formoterol
CID000005584,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,991,Trimipramine
CID000005584,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Trimipramine
CID000005584,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,991,Trimipramine
CID000005584,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,800,Trimipramine
CID000005584,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,991,Trimipramine
CID000004993,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,Pyrimethamine
CID000004993,1719,DHFR,9606.ENSP00000396308,Dihydrofolate reductase,inhibition,inhibition,t,958,Pyrimethamine
CID000004993,1719,DHFR,9606.ENSP00000396308,Dihydrofolate reductase,inhibition,inhibition,t,990,Pyrimethamine
CID000002726,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,50-53-3
CID000002726,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,800,50-53-3
CID000002726,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,999,50-53-3
CID000002726,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,50-53-3
CID000002726,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,50-53-3
CID000002726,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,50-53-3
CID000002726,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,50-53-3
CID000002726,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,50-53-3
CID000002726,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,50-53-3
CID000002726,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,50-53-3
CID000002726,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,50-53-3
CID000002726,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,binding,inhibition,t,800,50-53-3
CID000002726,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,activation,t,991,50-53-3
CID000002726,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,998,50-53-3
CID000002726,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,50-53-3
CID000002726,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,50-53-3
CID000002726,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,50-53-3
CID000002726,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,50-53-3
CID000002726,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,inhibition,t,800,50-53-3
CID000002726,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,998,50-53-3
CID000002726,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,50-53-3
CID000002726,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,50-53-3
CID000002726,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,50-53-3
CID003062316,10188,TNK2,9606.ENSP00000371341,Activated CDC42 kinase 1,inhibition,inhibition,t,800,302962-49-8
CID003062316,25,ABL1,9606.ENSP00000361423,Tyrosine-protein kinase ABL1,inhibition,inhibition,t,800,302962-49-8
CID003062316,25,ABL1,9606.ENSP00000361423,Tyrosine-protein kinase ABL1,inhibition,inhibition,t,700,302962-49-8
CID003062316,2065,ERBB3,9606.ENSP00000267101,Receptor tyrosine-protein kinase erbB-3,inhibition,inhibition,t,800,302962-49-8
CID003062316,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,957,302962-49-8
CID003062316,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,991,302962-49-8
CID003062316,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,957,302962-49-8
CID003062316,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,991,302962-49-8
CID003062316,1436,CSF1R,9606.ENSP00000286301,Macrophage colony-stimulating factor 1 receptor,inhibition,inhibition,t,800,302962-49-8
CID003062316,4067,LYN,9606.ENSP00000428924,Tyrosine-protein kinase Lyn,inhibition,inhibition,t,907,302962-49-8
CID003062316,1969,EPHA2,9606.ENSP00000351209,Ephrin type-A receptor 2,inhibition,inhibition,t,800,302962-49-8
CID003062316,1969,EPHA2,9606.ENSP00000351209,Ephrin type-A receptor 2,inhibition,inhibition,t,991,302962-49-8
CID003062316,2534,FYN,9606.ENSP00000346671,Tyrosine-protein kinase Fyn,inhibition,inhibition,t,800,302962-49-8
CID000005210,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,958,Sibutramine
CID000005210,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,958,Sibutramine
CID000005210,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,958,Sibutramine
CID000004168,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,991,364-62-5
CID000004168,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,364-62-5
CID000004168,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,activation,activation,t,958,364-62-5
CID000004168,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,700,364-62-5
CID000004168,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,364-62-5
CID000003032,54658,UGT1A1,9606.ENSP00000304845,UDP-glucuronosyltransferase 1-1,inhibition,inhibition,t,700,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,957,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,999,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,activation,activation,t,700,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,700,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,activation,activation,t,800,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000003032,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate"
CID000001775,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,activation,activation,t,700,phenytoin
CID000005212,8654,PDE5A,9606.ENSP00000347046,"cGMP-specific 3',5'-cyclic phosphodiesterase",activation,activation,t,800,Sildenafil
CID000005212,8654,PDE5A,9606.ENSP00000347046,"cGMP-specific 3',5'-cyclic phosphodiesterase",inhibition,inhibition,t,990,Sildenafil
CID000005212,8654,PDE5A,9606.ENSP00000347046,"cGMP-specific 3',5'-cyclic phosphodiesterase",inhibition,inhibition,t,999,Sildenafil
CID000002170,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,999,Amoxapine
CID000002170,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,991,Amoxapine
CID000002170,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,Amoxapine
CID000002170,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,inhibition,inhibition,t,991,Amoxapine
CID000002170,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,991,Amoxapine
CID000002170,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,991,Amoxapine
CID000002170,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,991,Amoxapine
CID000002170,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,inhibition,inhibition,t,991,Amoxapine
CID000002170,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,binding,inhibition,t,800,Amoxapine
CID000002170,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,991,Amoxapine
CID000002170,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,999,Amoxapine
CID000002170,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,999,Amoxapine
CID000002170,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,inhibition,inhibition,t,991,Amoxapine
CID000002170,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,991,Amoxapine
CID000002170,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,991,Amoxapine
CID000002170,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,inhibition,inhibition,t,991,Amoxapine
CID000002170,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,Amoxapine
CID000003108,8654,PDE5A,9606.ENSP00000347046,"cGMP-specific 3',5'-cyclic phosphodiesterase",inhibition,inhibition,t,987,Dipyridamole
CID000002578,2936,GSR,9606.ENSP00000221130,"Glutathione reductase, mitochondrial",inhibition,inhibition,t,987,Carmustine
CID000002578,2936,GSR,9606.ENSP00000221130,"Glutathione reductase, mitochondrial",inhibition,inhibition,t,957,Carmustine
CID000002156,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,991,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium"
CID000002156,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,800,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium"
CID000002156,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,999,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium"
CID000002156,1558,CYP2C8,9606.ENSP00000360317,Cytochrome P450 2C8,inhibition,inhibition,t,700,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium"
CID000005656,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,991,93413-69-5
CID000005656,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,991,93413-69-5
CID000005656,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,991,93413-69-5
CID000036811,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,991,Dobutamine
CID000036811,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,activation,t,998,Dobutamine
CID004659569,1312,COMT,9606.ENSP00000354511,Catechol O-methyltransferase,inhibition,inhibition,t,990,tolcapone
CID004659569,1312,COMT,9606.ENSP00000354511,Catechol O-methyltransferase,binding,inhibition,t,989,tolcapone
CID004659569,1312,COMT,9606.ENSP00000354511,Catechol O-methyltransferase,inhibition,inhibition,t,997,tolcapone
CID000005472,1544,CYP1A2,9606.ENSP00000342007,Cytochrome P450 1A2,inhibition,inhibition,t,700,Ticlopidine
CID000005472,1555,CYP2B6,9606.ENSP00000324648,Cytochrome P450 2B6,inhibition,inhibition,t,800,Ticlopidine
CID000005472,1555,CYP2B6,9606.ENSP00000324648,Cytochrome P450 2B6,inhibition,inhibition,t,700,Ticlopidine
CID000005472,1557,CYP2C19,9606.ENSP00000360372,Cytochrome P450 2C19,inhibition,inhibition,t,800,Ticlopidine
CID000005472,1557,CYP2C19,9606.ENSP00000360372,Cytochrome P450 2C19,inhibition,inhibition,t,700,Ticlopidine
CID000005472,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,957,Ticlopidine
CID000013342,10383,TUBB4B,9606.ENSP00000341289,Tubulin beta-4B chain,activation,activation,t,702,(+)-Vinblastine
CID000013342,10383,TUBB4B,9606.ENSP00000341289,Tubulin beta-4B chain,inhibition,inhibition,t,832,(+)-Vinblastine
CID000004473,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,700,HMS1361F11
CID000083786,3251,HPRT1,9606.ENSP00000298556,Hypoxanthine-guanine phosphoribosyltransferase,inhibition,inhibition,t,800,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one"
CID000004829,5467,PPARD,9606.ENSP00000310928,Peroxisome proliferator-activated receptor delta,activation,activation,t,700,111025-46-8
CID000004829,2908,NR3C1,9606.ENSP00000231509,Glucocorticoid receptor,activation,activation,t,800,111025-46-8
CID000004829,5468,PPARG,9606.ENSP00000287820,Peroxisome proliferator-activated receptor gamma,activation,activation,t,999,111025-46-8
CID000124087,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,Desloratadine
CID000124087,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Desloratadine
CID000002551,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,activation,t,998,Carbachol
CID000002551,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,activation,activation,t,700,Carbachol
CID000002551,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,activation,t,998,Carbachol
CID000002551,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,activation,t,998,Carbachol
CID000002551,1137,CHRNA4,9606.ENSP00000359285,Neuronal acetylcholine receptor subunit alpha-4,activation,activation,t,800,Carbachol
CID000002551,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,activation,activation,t,987,Carbachol
CID000002551,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,activation,t,998,Carbachol
CID000002551,1135,CHRNA2,9606.ENSP00000385026,Neuronal acetylcholine receptor subunit alpha-2,activation,activation,t,958,Carbachol
CID000002551,1135,CHRNA2,9606.ENSP00000385026,Neuronal acetylcholine receptor subunit alpha-2,inhibition,inhibition,t,800,Carbachol
CID000004499,1544,CYP1A2,9606.ENSP00000342007,Cytochrome P450 1A2,inhibition,inhibition,t,700,63675-72-9
CID000002678,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,958,Cetirizine
CID000002370,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,activation,t,800,Bethanechol
CID000002370,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,activation,t,800,Bethanechol
CID000002370,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,activation,t,800,Bethanechol
CID000002375,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,999,Bicalutamide
CID000002375,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,997,Bicalutamide
CID000000942,1142,CHRNB3,9606.ENSP00000289957,Neuronal acetylcholine receptor subunit beta-3,activation,activation,t,991,22083-74-5
CID000000942,1143,CHRNB4,9606.ENSP00000261751,Neuronal acetylcholine receptor subunit beta-4,activation,activation,t,991,22083-74-5
CID000000942,1141,CHRNB2,9606.ENSP00000357461,Neuronal acetylcholine receptor subunit beta-2,activation,activation,t,991,22083-74-5
CID000000942,89832,CHRFAM7A,9606.ENSP00000299847,CHRNA7-FAM7A fusion protein,activation,activation,t,991,22083-74-5
CID000000942,1138,CHRNA5,9606.ENSP00000299565,Neuronal acetylcholine receptor subunit alpha-5,activation,activation,t,991,22083-74-5
CID000000942,1137,CHRNA4,9606.ENSP00000359285,Neuronal acetylcholine receptor subunit alpha-4,activation,activation,t,991,22083-74-5
CID000000942,1136,CHRNA3,9606.ENSP00000315602,Neuronal acetylcholine receptor subunit alpha-3,activation,activation,t,991,22083-74-5
CID000000942,1135,CHRNA2,9606.ENSP00000385026,Neuronal acetylcholine receptor subunit alpha-2,activation,activation,t,991,22083-74-5
CID000000942,57053,CHRNA10,9606.ENSP00000250699,Neuronal acetylcholine receptor subunit alpha-10,activation,activation,t,991,22083-74-5
CID000000942,55584,CHRNA9,9606.ENSP00000312663,Neuronal acetylcholine receptor subunit alpha-9,activation,activation,t,991,22083-74-5
CID000000942,8973,CHRNA6,9606.ENSP00000276410,Neuronal acetylcholine receptor subunit alpha-6,activation,activation,t,991,22083-74-5
CID006436173,8856,NR1I2,9606.ENSP00000336528,Nuclear receptor subfamily 1 group I member 2,activation,activation,t,958,80621-81-4
CID006436173,8856,NR1I2,9606.ENSP00000336528,Nuclear receptor subfamily 1 group I member 2,activation,activation,t,800,80621-81-4
CID000000937,8843,HCAR3,9606.ENSP00000436714,Hydroxycarboxylic acid receptor 3,activation,activation,t,991,Nicotinate
CID000000937,338442,HCAR2,9606.ENSP00000375066,Hydroxycarboxylic acid receptor 2,activation,activation,t,997,Nicotinate
CID000000937,338442,HCAR2,9606.ENSP00000375066,Hydroxycarboxylic acid receptor 2,binding,activation,t,958,Nicotinate
CID000002725,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,chlorphenamine
CID000002725,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,999,chlorphenamine
CID000002725,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,958,chlorphenamine
CID000005095,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,activation,activation,t,991,91374-21-9
CID000005095,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,activation,t,800,91374-21-9
CID000005095,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,91374-21-9
CID000005095,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,activation,activation,t,958,91374-21-9
CID000005095,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,activation,activation,t,958,91374-21-9
CID000005095,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,91374-21-9
CID000005095,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,activation,activation,t,958,91374-21-9
CID000005095,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,activation,activation,t,958,91374-21-9
CID000005095,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,activation,activation,t,958,91374-21-9
CID000005095,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,activation,activation,t,958,91374-21-9
CID000005095,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,activation,activation,t,958,91374-21-9
CID000005095,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,activation,activation,t,991,91374-21-9
CID000005095,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,91374-21-9
CID000005090,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,700,Rofecoxib
CID000005090,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,957,Rofecoxib
CID000005090,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,Rofecoxib
CID000005090,5732,PTGER2,9606.ENSP00000245457,Prostaglandin E2 receptor EP2 subtype,binding,inhibition,t,800,Rofecoxib
CID000051634,57704,GBA2,9606.ENSP00000367343,Non-lysosomal glucosylceramidase,inhibition,inhibition,t,800,miglustat
CID000003157,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,998,Doxazosin
CID000003157,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,activation,activation,t,700,Doxazosin
CID000003157,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,999,Doxazosin
CID000003157,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,binding,inhibition,t,800,Doxazosin
CID000003157,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,998,Doxazosin
CID000003157,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,Doxazosin
CID000003157,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,Doxazosin
CID000003157,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,958,Doxazosin
CID000003152,590,BCHE,9606.ENSP00000264381,Cholinesterase,inhibition,inhibition,t,887,120014-06-4
CID000003152,590,BCHE,9606.ENSP00000264381,Cholinesterase,inhibition,inhibition,t,700,120014-06-4
CID000003397,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,800,Flutamide
CID000003397,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,997,Flutamide
CID000003397,367,AR,9606.ENSP00000363822,Androgen receptor,activation,activation,t,700,Flutamide
CID000068740,4313,MMP2,9606.ENSP00000219070,72 kDa type IV collagenase,inhibition,inhibition,t,990,118072-93-8
CID000068740,9453,GGPS1,9606.ENSP00000282841,Geranylgeranyl pyrophosphate synthase,inhibition,inhibition,t,800,118072-93-8
CID000068740,9453,GGPS1,9606.ENSP00000282841,Geranylgeranyl pyrophosphate synthase,inhibition,inhibition,t,987,118072-93-8
CID000068740,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,activation,activation,t,800,118072-93-8
CID000068740,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,inhibition,inhibition,t,999,118072-93-8
CID000068740,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,activation,activation,t,700,118072-93-8
CID000104741,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,957,Fulvestrant
CID000104741,367,AR,9606.ENSP00000363822,Androgen receptor,inhibition,inhibition,t,700,Fulvestrant
CID000104741,8856,NR1I2,9606.ENSP00000336528,Nuclear receptor subfamily 1 group I member 2,activation,activation,t,700,Fulvestrant
CID000005578,1719,DHFR,9606.ENSP00000396308,Dihydrofolate reductase,inhibition,inhibition,t,991,Trimethoprim
CID000005578,1719,DHFR,9606.ENSP00000396308,Dihydrofolate reductase,inhibition,inhibition,t,998,Trimethoprim
CID000005578,7298,TYMS,9606.ENSP00000315644,Thymidylate synthase,inhibition,inhibition,t,991,Trimethoprim
CID000003825,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,998,Ketoprofen
CID000003825,6580,SLC22A1,9606.ENSP00000355930,Solute carrier family 22 member 1,inhibition,inhibition,t,700,Ketoprofen
CID000003825,114571,SLC22A9,9606.ENSP00000279178,Solute carrier family 22 member 9,inhibition,inhibition,t,700,Ketoprofen
CID000003825,55867,SLC22A11,9606.ENSP00000301891,Solute carrier family 22 member 11,inhibition,inhibition,t,700,Ketoprofen
CID000003825,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,Ketoprofen
CID000003825,10864,SLC22A7,9606.ENSP00000361666,Solute carrier family 22 member 7,inhibition,inhibition,t,700,Ketoprofen
CID000003385,7298,TYMS,9606.ENSP00000315644,Thymidylate synthase,inhibition,inhibition,t,998,Fluorouracil
CID000003385,7298,TYMS,9606.ENSP00000315644,Thymidylate synthase,inhibition,inhibition,t,987,Fluorouracil
CID000003385,7298,TYMS,9606.ENSP00000315644,Thymidylate synthase,activation,activation,t,700,Fluorouracil
CID000002801,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,303-49-1
CID000002801,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,998,303-49-1
CID000002801,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,998,303-49-1
CID000002801,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,303-49-1
CID000002801,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,303-49-1
CID000002801,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,inhibition,inhibition,t,998,303-49-1
CID000002801,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,998,303-49-1
CID000002801,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,303-49-1
CID000002801,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,303-49-1
CID000004440,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,activation,activation,t,991,121679-13-8
CID000004440,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,958,121679-13-8
CID000004440,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,activation,activation,t,958,121679-13-8
CID000004440,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,121679-13-8
CID000072054,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,958,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide"
CID000072054,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide"
CID000072054,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide"
CID000072054,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide"
CID000060164,5915,RARB,9606.ENSP00000332296,Retinoic acid receptor beta,activation,activation,t,800,Adapalene
CID000060164,5914,RARA,9606.ENSP00000254066,Retinoic acid receptor alpha,activation,activation,t,800,Adapalene
CID000004485,1544,CYP1A2,9606.ENSP00000342007,Cytochrome P450 1A2,inhibition,inhibition,t,700,21829-25-4
CID000004485,775,CACNA1C,9606.ENSP00000266376,Voltage-dependent L-type calcium channel subunit alpha-1C,inhibition,inhibition,t,991,21829-25-4
CID000004485,776,CACNA1D,9606.ENSP00000288139,Voltage-dependent L-type calcium channel subunit alpha-1D,inhibition,inhibition,t,991,21829-25-4
CID000004485,779,CACNA1S,9606.ENSP00000355192,Voltage-dependent L-type calcium channel subunit alpha-1S,inhibition,inhibition,t,991,21829-25-4
CID000003007,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,700,Amphetamine
CID000005381,5915,RARB,9606.ENSP00000332296,Retinoic acid receptor beta,activation,activation,t,958,118292-40-3
CID000005381,5914,RARA,9606.ENSP00000254066,Retinoic acid receptor alpha,activation,activation,t,958,118292-40-3
CID000216239,2322,FLT3,9606.ENSP00000241453,Receptor-type tyrosine-protein kinase FLT3,inhibition,inhibition,t,999,Sorafenib
CID000216239,2322,FLT3,9606.ENSP00000241453,Receptor-type tyrosine-protein kinase FLT3,inhibition,inhibition,t,990,Sorafenib
CID000216239,2321,FLT1,9606.ENSP00000282397,Vascular endothelial growth factor receptor 1,inhibition,inhibition,t,998,Sorafenib
CID000216239,2324,FLT4,9606.ENSP00000261937,Vascular endothelial growth factor receptor 3,inhibition,inhibition,t,991,Sorafenib
CID000216239,3791,KDR,9606.ENSP00000263923,Vascular endothelial growth factor receptor 2,inhibition,inhibition,t,957,Sorafenib
CID000216239,3791,KDR,9606.ENSP00000263923,Vascular endothelial growth factor receptor 2,inhibition,inhibition,t,991,Sorafenib
CID000216239,25,ABL1,9606.ENSP00000361423,Tyrosine-protein kinase ABL1,inhibition,inhibition,t,700,Sorafenib
CID000216239,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,992,Sorafenib
CID000216239,5159,PDGFRB,9606.ENSP00000261799,Platelet-derived growth factor receptor beta,inhibition,inhibition,t,997,Sorafenib
CID000216239,5156,PDGFRA,9606.ENSP00000257290,Platelet-derived growth factor receptor alpha,inhibition,inhibition,t,839,Sorafenib
CID000216239,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,957,Sorafenib
CID000216239,3815,KIT,9606.ENSP00000288135,Mast/stem cell growth factor receptor Kit,inhibition,inhibition,t,991,Sorafenib
CID000216239,2932,GSK3B,9606.ENSP00000324806,Glycogen synthase kinase-3 beta,activation,activation,t,700,Sorafenib
CID000216239,5979,RET,9606.ENSP00000347942,Extracellular cell-membrane anchored RET cadherin 120 kDa fragment,inhibition,inhibition,t,998,Sorafenib
CID000216239,5979,RET,9606.ENSP00000347942,Extracellular cell-membrane anchored RET cadherin 120 kDa fragment,inhibition,inhibition,t,999,Sorafenib
CID000057537,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,activation,activation,t,958,(Â±)-Rotigotine
CID000057537,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,activation,activation,t,958,(Â±)-Rotigotine
CID000057537,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,activation,t,800,(Â±)-Rotigotine
CID005493444,5972,REN,9606.ENSP00000272190,Renin,inhibition,inhibition,t,938,Aliskiren
CID005493444,5972,REN,9606.ENSP00000272190,Renin,activation,activation,t,957,Aliskiren
CID005493444,5972,REN,9606.ENSP00000272190,Renin,inhibition,inhibition,t,990,Aliskiren
CID000060852,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,inhibition,inhibition,t,987,Ibandronate
CID000060852,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,inhibition,inhibition,t,800,Ibandronate
CID000003042,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,991,Dicyclomine
CID000003042,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,Dicyclomine
CID000003510,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,958,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide
CID000003066,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,activation,activation,t,800,"5â²-Benzyl-12â²-hydroxy-2â²-methyl-3â²,6â²,18-trioxo-9,10-dihydroergotaman"
CID000003066,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,"5â²-Benzyl-12â²-hydroxy-2â²-methyl-3â²,6â²,18-trioxo-9,10-dihydroergotaman"
CID000003066,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,800,"5â²-Benzyl-12â²-hydroxy-2â²-methyl-3â²,6â²,18-trioxo-9,10-dihydroergotaman"
CID000003066,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,"5â²-Benzyl-12â²-hydroxy-2â²-methyl-3â²,6â²,18-trioxo-9,10-dihydroergotaman"
CID000003066,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,"5â²-Benzyl-12â²-hydroxy-2â²-methyl-3â²,6â²,18-trioxo-9,10-dihydroergotaman"
CID000074989,1723,DHODH,9606.ENSP00000219240,"Dihydroorotate dehydrogenase (quinone), mitochondrial",inhibition,inhibition,t,991,95233-18-4
CID000051263,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,activation,activation,t,999,71195-58-9
CID000051263,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,binding,activation,t,800,71195-58-9
CID000004205,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,958,85650-52-8
CID000004205,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,85650-52-8
CID000004205,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,800,85650-52-8
CID000004205,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,958,85650-52-8
CID000004205,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,85650-52-8
CID000004205,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,958,85650-52-8
CID000004205,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,958,85650-52-8
CID000004205,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,958,85650-52-8
CID000004205,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,991,85650-52-8
CID000004205,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,85650-52-8
CID000004205,11255,HRH3,9606.ENSP00000342560,Histamine H3 receptor,inhibition,inhibition,t,958,85650-52-8
CID000005401,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,958,Terazosin
CID000005401,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,991,Terazosin
CID000005401,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,binding,inhibition,t,991,Terazosin
CID000005401,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,958,Terazosin
CID000005401,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,991,Terazosin
CID000005401,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,958,Terazosin
CID000005401,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,991,Terazosin
CID000005533,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,Trazodone
CID000005533,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Trazodone
CID000005533,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,998,Trazodone
CID000005533,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,998,Trazodone
CID000005533,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,958,Trazodone
CID000005533,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Trazodone
CID000005533,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,Trazodone
CID000005533,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Trazodone
CID000005533,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,800,Trazodone
CID000005533,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,activation,activation,t,998,Trazodone
CID000005533,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,Trazodone
CID000005533,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,activation,activation,t,998,Trazodone
CID000005533,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,Trazodone
CID000005358,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,Sumatriptan
CID000005358,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,activation,activation,t,991,Sumatriptan
CID000005358,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,958,Sumatriptan
CID000005358,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,activation,activation,t,991,Sumatriptan
CID000005358,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,Sumatriptan
CID000005358,3361,HTR5A,9606.ENSP00000287907,5-hydroxytryptamine receptor 5A,binding,activation,t,991,Sumatriptan
CID000005358,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,binding,inhibition,t,800,Sumatriptan
CID000005358,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,Sumatriptan
CID000005358,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,activation,activation,t,991,Sumatriptan
CID000005358,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,Sumatriptan
CID000004819,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,activation,t,800,Pilocarpine
CID000003348,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,83799-24-0
CID000003348,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,83799-24-0
CID000003348,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,activation,activation,t,700,83799-24-0
CID000003345,4985,OPRD1,9606.ENSP00000234961,Delta-type opioid receptor,activation,activation,t,991,Fentanyl
CID000003345,4985,OPRD1,9606.ENSP00000234961,Delta-type opioid receptor,binding,activation,t,800,Fentanyl
CID000003345,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,activation,activation,t,990,Fentanyl
CID000003345,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,activation,activation,t,998,Fentanyl
CID000003345,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,binding,activation,t,800,Fentanyl
CID000005453,1555,CYP2B6,9606.ENSP00000324648,Cytochrome P450 2B6,inhibition,inhibition,t,800,thiotepa
CID000005453,1555,CYP2B6,9606.ENSP00000324648,Cytochrome P450 2B6,inhibition,inhibition,t,700,thiotepa
CID000068844,762,CA4,9606.ENSP00000300900,Carbonic anhydrase 4,inhibition,inhibition,t,958,138890-62-7
CID000068844,760,CA2,9606.ENSP00000285379,Carbonic anhydrase 2,inhibition,inhibition,t,958,138890-62-7
CID000005002,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,991,111974-69-7
CID000005002,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,991,111974-69-7
CID000005002,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,999,111974-69-7
CID000005002,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,958,111974-69-7
CID000005002,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,activation,activation,t,800,111974-69-7
CID000005002,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,991,111974-69-7
CID000005002,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,111974-69-7
CID000005002,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,111974-69-7
CID000005002,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,991,111974-69-7
CID000005002,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,991,111974-69-7
CID000005002,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,991,111974-69-7
CID000005002,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,111974-69-7
CID000005002,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,800,111974-69-7
CID000005002,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,991,111974-69-7
CID000005002,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,111974-69-7
CID000005002,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,991,111974-69-7
CID000005002,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,111974-69-7
CID000005002,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,inhibition,inhibition,t,991,111974-69-7
CID000005184,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,(-)-Scopolamine
CID000005184,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,(-)-Scopolamine
CID000005184,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,(-)-Scopolamine
CID000003372,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,998,Fluphenazine
CID000003372,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,inhibition,t,800,Fluphenazine
CID000003372,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,Fluphenazine
CID000003372,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,800,Fluphenazine
CID000003372,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,Fluphenazine
CID000003372,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,activation,t,991,Fluphenazine
CID000003372,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Fluphenazine
CID000003372,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,Fluphenazine
CID000003372,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,Fluphenazine
CID000004585,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,activation,activation,t,999,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,999,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,958,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,activation,activation,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3361,HTR5A,9606.ENSP00000287907,5-hydroxytryptamine receptor 5A,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,inhibition,inhibition,t,998,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004585,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine"
CID000004771,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,958,122-09-8
CID000004771,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,958,122-09-8
CID000005245,2224,FDPS,9606.ENSP00000349078,Farnesyl pyrophosphate synthase,inhibition,inhibition,t,999,Risedronic acid
CID000125017,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,958,desvenlafaxine
CID000125017,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,958,desvenlafaxine
CID000004595,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,958,Ondansetron
CID000005070,6334,SCN8A,9606.ENSP00000346534,Sodium channel protein type 8 subunit alpha,inhibition,inhibition,t,800,Riluzole
CID000005070,6331,SCN5A,9606.ENSP00000328968,Sodium channel protein type 5 subunit alpha,inhibition,inhibition,t,991,Riluzole
CID000005078,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,800,144034-80-0
CID000005078,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,activation,activation,t,958,144034-80-0
CID000005078,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,991,144034-80-0
CID000005078,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,800,144034-80-0
CID000005078,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,activation,activation,t,958,144034-80-0
CID000005078,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,800,144034-80-0
CID000003827,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,958,34580-13-7
CID000003827,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,34580-13-7
CID000003826,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,938,Ketorolac
CID000003826,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,800,Ketorolac
CID000003168,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,800,Droperidol
CID000003168,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,Droperidol
CID000003168,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,Droperidol
CID000003168,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,800,Droperidol
CID000004943,760,CA2,9606.ENSP00000285379,Carbonic anhydrase 2,inhibition,inhibition,t,700,Propofol
CID000004946,1544,CYP1A2,9606.ENSP00000342007,Cytochrome P450 1A2,inhibition,inhibition,t,800,b-Propranolol
CID000004946,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,b-Propranolol
CID000004946,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,b-Propranolol
CID000004946,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,674,b-Propranolol
CID000004946,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,960,b-Propranolol
CID000004946,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,998,b-Propranolol
CID000004946,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,800,b-Propranolol
CID000004946,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,700,b-Propranolol
CID000004946,7852,CXCR4,9606.ENSP00000386884,C-X-C chemokine receptor type 4,inhibition,inhibition,t,800,b-Propranolol
CID000004946,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,activation,activation,t,674,b-Propranolol
CID000004946,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,inhibition,inhibition,t,960,b-Propranolol
CID000004946,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,inhibition,inhibition,t,998,b-Propranolol
CID000004946,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,binding,inhibition,t,800,b-Propranolol
CID000004946,3361,HTR5A,9606.ENSP00000287907,5-hydroxytryptamine receptor 5A,binding,inhibition,t,800,b-Propranolol
CID000002244,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,998,50-78-2
CID000002244,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,50-78-2
CID000002244,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,activation,activation,t,899,50-78-2
CID000002244,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,999,50-78-2
CID000002244,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,activation,activation,t,900,50-78-2
CID000000564,5340,PLG,9606.ENSP00000308938,"Plasmin heavy chain A, short form",inhibition,inhibition,t,957,Aminocaproic acid
CID000000564,5340,PLG,9606.ENSP00000308938,"Plasmin heavy chain A, short form",inhibition,inhibition,t,991,Aminocaproic acid
CID000004614,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,958,Oxaprozin
CID000119607,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,997,181695-72-7
CID000004189,1557,CYP2C19,9606.ENSP00000360372,Cytochrome P450 2C19,inhibition,inhibition,t,700,22916-47-8
CID000004189,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,700,22916-47-8
CID000082146,5468,PPARG,9606.ENSP00000287820,Peroxisome proliferator-activated receptor gamma,activation,activation,t,800,Bexarotene
CID000082146,6256,RXRA,9606.ENSP00000419692,Retinoic acid receptor RXR-alpha,activation,activation,t,958,Bexarotene
CID000082146,6258,RXRG,9606.ENSP00000352900,Retinoic acid receptor RXR-gamma,activation,activation,t,958,Bexarotene
CID000115237,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,958,144598-75-4
CID000115237,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,inhibition,t,800,144598-75-4
CID000115237,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,144598-75-4
CID000115237,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,800,144598-75-4
CID000115237,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,144598-75-4
CID000115237,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,144598-75-4
CID000115237,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,activation,activation,t,800,144598-75-4
CID000115237,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,144598-75-4
CID000115237,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,activation,activation,t,800,144598-75-4
CID000115237,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,800,144598-75-4
CID000115237,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,800,144598-75-4
CID000115237,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,800,144598-75-4
CID000115237,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,800,144598-75-4
CID000115237,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,inhibition,inhibition,t,800,144598-75-4
CID000002756,55244,SLC47A1,9606.ENSP00000270570,Multidrug and toxin extrusion protein 1,inhibition,inhibition,t,700,Cimetidine
CID000002756,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,inhibition,inhibition,t,998,Cimetidine
CID000002756,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,958,Cimetidine
CID000002756,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,activation,activation,t,800,Cimetidine
CID000002756,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,inhibition,inhibition,t,800,Cimetidine
CID000002818,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,998,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3354,HTR1E,9606.ENSP00000307766,5-hydroxytryptamine receptor 1E,binding,activation,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,activation,t,998,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3361,HTR5A,9606.ENSP00000287907,5-hydroxytryptamine receptor 5A,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3362,HTR6,9606.ENSP00000289753,5-hydroxytryptamine receptor 6,inhibition,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,activation,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,inhibition,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3355,HTR1F,9606.ENSP00000322924,5-hydroxytryptamine receptor 1F,binding,activation,t,998,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,activation,t,998,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,inhibition,inhibition,t,991,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000002818,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine"
CID000003784,775,CACNA1C,9606.ENSP00000266376,Voltage-dependent L-type calcium channel subunit alpha-1C,inhibition,inhibition,t,958,75695-93-1
CID000003784,776,CACNA1D,9606.ENSP00000288139,Voltage-dependent L-type calcium channel subunit alpha-1D,inhibition,inhibition,t,958,75695-93-1
CID000003784,779,CACNA1S,9606.ENSP00000355192,Voltage-dependent L-type calcium channel subunit alpha-1S,inhibition,inhibition,t,958,75695-93-1
CID000003957,1557,CYP2C19,9606.ENSP00000360372,Cytochrome P450 2C19,inhibition,inhibition,t,800,79794-75-5
CID000003957,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,79794-75-5
CID000003957,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,79794-75-5
CID000003957,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,79794-75-5
CID000004991,590,BCHE,9606.ENSP00000264381,Cholinesterase,inhibition,inhibition,t,958,Pyridostigmine
CID000003308,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,999,rac-Etodolac
CID000003308,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,rac-Etodolac
CID000003494,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,958,Glycopyrrolate
CID000003494,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,Glycopyrrolate
CID000003494,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,800,Glycopyrrolate
CID000002405,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,997,66722-44-9
CID000002405,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,958,66722-44-9
CID000004828,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,13523-86-9
CID000004828,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,inhibition,inhibition,t,958,13523-86-9
CID000004828,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,13523-86-9
CID000004828,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,987,13523-86-9
CID000004601,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,958,Orphenadrine
CID000004601,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,958,Orphenadrine
CID000004601,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Orphenadrine
CID000002520,1558,CYP2C8,9606.ENSP00000360317,Cytochrome P450 2C8,inhibition,inhibition,t,700,52-53-9
CID000002520,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,52-53-9
CID000002520,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,997,52-53-9
CID000002520,340273,ABCB5,9606.ENSP00000384881,ATP-binding cassette sub-family B member 5,inhibition,inhibition,t,800,52-53-9
CID000002520,3738,KCNA3,9606.ENSP00000358784,Potassium voltage-gated channel subfamily A member 3,inhibition,inhibition,t,700,52-53-9
CID000002520,775,CACNA1C,9606.ENSP00000266376,Voltage-dependent L-type calcium channel subunit alpha-1C,inhibition,inhibition,t,991,52-53-9
CID000002520,776,CACNA1D,9606.ENSP00000288139,Voltage-dependent L-type calcium channel subunit alpha-1D,inhibition,inhibition,t,991,52-53-9
CID000002520,779,CACNA1S,9606.ENSP00000355192,Voltage-dependent L-type calcium channel subunit alpha-1S,inhibition,inhibition,t,991,52-53-9
CID000002520,778,CACNA1F,9606.ENSP00000365441,Voltage-dependent L-type calcium channel subunit alpha-1F,inhibition,inhibition,t,991,52-53-9
CID000002520,8913,CACNA1G,9606.ENSP00000352011,Voltage-dependent T-type calcium channel subunit alpha-1G,inhibition,inhibition,t,998,52-53-9
CID000041693,4985,OPRD1,9606.ENSP00000234961,Delta-type opioid receptor,activation,activation,t,958,Sufentanil
CID000041693,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,activation,activation,t,958,Sufentanil
CID000041693,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,binding,activation,t,998,Sufentanil
CID000002092,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,991,Alfuzosin
CID000002092,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,958,Alfuzosin
CID000002092,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,991,Alfuzosin
CID000002092,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Alfuzosin
CID000110635,50940,PDE11A,9606.ENSP00000286063,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",inhibition,inhibition,t,958,171596-29-5
CID000110635,8654,PDE5A,9606.ENSP00000347046,"cGMP-specific 3',5'-cyclic phosphodiesterase",inhibition,inhibition,t,997,171596-29-5
CID000004927,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,991,(Â±)-Promethazine
CID000004927,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,991,(Â±)-Promethazine
CID000004927,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,991,(Â±)-Promethazine
CID000004927,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,991,(Â±)-Promethazine
CID000004927,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,991,(Â±)-Promethazine
CID000004927,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,(Â±)-Promethazine
CID000004927,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,59340,HRH4,9606.ENSP00000256906,Histamine H4 receptor,binding,inhibition,t,800,(Â±)-Promethazine
CID000004927,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,(Â±)-Promethazine
CID000003559,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,800,Haloperidol
CID000003559,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,998,Haloperidol
CID000003559,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,958,Haloperidol
CID000003559,3351,HTR1B,9606.ENSP00000358963,5-hydroxytryptamine receptor 1B,binding,inhibition,t,800,Haloperidol
CID000003559,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,Haloperidol
CID000003559,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Haloperidol
CID000003559,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Haloperidol
CID000003559,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,binding,inhibition,t,800,Haloperidol
CID000003559,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Haloperidol
CID000003559,1816,DRD5,9606.ENSP00000306129,D(1B) dopamine receptor,binding,activation,t,991,Haloperidol
CID000003559,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,800,Haloperidol
CID000003559,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,Haloperidol
CID000003559,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Haloperidol
CID000003559,3357,HTR2B,9606.ENSP00000258400,5-hydroxytryptamine receptor 2B,binding,inhibition,t,800,Haloperidol
CID000003559,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,Haloperidol
CID000003559,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,Haloperidol
CID000004634,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,958,oxybutynin
CID000004634,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,oxybutynin
CID000004634,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,998,oxybutynin
CID000002662,760,CA2,9606.ENSP00000285379,Carbonic anhydrase 2,inhibition,inhibition,t,700,Celecoxib
CID000002662,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,800,Celecoxib
CID000002662,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,700,Celecoxib
CID000002662,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,Celecoxib
CID000004058,4985,OPRD1,9606.ENSP00000234961,Delta-type opioid receptor,binding,activation,t,800,57-42-1
CID000004058,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,activation,activation,t,991,57-42-1
CID000004058,4988,OPRM1,9606.ENSP00000394624,Mu-type opioid receptor,binding,activation,t,800,57-42-1
CID000002771,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,800,Citalopram
CID000002771,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,800,Citalopram
CID000002771,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,991,Citalopram
CID000002771,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,Citalopram
CID000003325,3274,HRH2,9606.ENSP00000366506,Histamine H2 receptor,inhibition,inhibition,t,991,Famotidine
CID000003869,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,inhibition,inhibition,t,987,Labetalol
CID000003869,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,inhibition,t,958,Labetalol
CID000003869,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,700,Labetalol
CID000003869,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Labetalol
CID000003869,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,binding,inhibition,t,800,Labetalol
CID000003869,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Labetalol
CID000003869,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,binding,inhibition,t,800,Labetalol
CID000003869,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,958,Labetalol
CID000003869,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,958,Labetalol
CID000003869,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,958,Labetalol
CID000003661,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,L-Hyoscyamine
CID000003661,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,L-Hyoscyamine
CID000003661,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,L-Hyoscyamine
CID000003661,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,L-Hyoscyamine
CID000004236,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,958,Modafinil
CID000005717,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,700,Zafirlukast
CID000005717,10800,CYSLTR1,9606.ENSP00000362401,Cysteinyl leukotriene receptor 1,inhibition,inhibition,t,998,Zafirlukast
CID000005717,10800,CYSLTR1,9606.ENSP00000362401,Cysteinyl leukotriene receptor 1,binding,inhibition,t,999,Zafirlukast
CID000003440,760,CA2,9606.ENSP00000285379,Carbonic anhydrase 2,inhibition,inhibition,t,700,Furosemide
CID000003446,781,CACNA2D1,9606.ENSP00000349320,Voltage-dependent calcium channel subunit alpha-2/delta-1,inhibition,inhibition,t,958,Gabapentin
CID000003446,9254,CACNA2D2,9606.ENSP00000418081,Voltage-dependent calcium channel subunit alpha-2/delta-2,inhibition,inhibition,t,991,Gabapentin
CID000003463,1559,CYP2C9,9606.ENSP00000260682,Cytochrome P450 2C9,inhibition,inhibition,t,800,Gemfibrozil
CID000003463,1558,CYP2C8,9606.ENSP00000360317,Cytochrome P450 2C8,inhibition,inhibition,t,700,Gemfibrozil
CID000003672,5743,PTGS2,9606.ENSP00000356438,Prostaglandin G/H synthase 2,inhibition,inhibition,t,999,Ibuprofen
CID000003672,5742,PTGS1,9606.ENSP00000354612,Prostaglandin G/H synthase 1,inhibition,inhibition,t,700,Ibuprofen
CID000003672,10864,SLC22A7,9606.ENSP00000361666,Solute carrier family 22 member 7,inhibition,inhibition,t,700,Ibuprofen
CID000004911,55867,SLC22A11,9606.ENSP00000301891,Solute carrier family 22 member 11,inhibition,inhibition,t,998,57-66-9
CID000004911,55867,SLC22A11,9606.ENSP00000301891,Solute carrier family 22 member 11,inhibition,inhibition,t,800,57-66-9
CID000004911,9376,SLC22A8,9606.ENSP00000337335,Solute carrier family 22 member 8,inhibition,inhibition,t,800,57-66-9
CID000004911,9376,SLC22A8,9606.ENSP00000337335,Solute carrier family 22 member 8,inhibition,inhibition,t,998,57-66-9
CID000004917,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,991,58-38-8
CID000004917,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,58-38-8
CID000004917,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,58-38-8
CID000004917,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,58-38-8
CID000004917,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,58-38-8
CID000003278,2950,GSTP1,9606.ENSP00000381607,Glutathione S-transferase P,inhibition,inhibition,t,700,58-54-8
CID000005978,10383,TUBB4B,9606.ENSP00000341289,Tubulin beta-4B chain,inhibition,inhibition,t,702,vincristine
CID000005978,7277,TUBA4A,9606.ENSP00000248437,Tubulin alpha-4A chain,inhibition,inhibition,t,991,vincristine
CID000065999,5468,PPARG,9606.ENSP00000287820,Peroxisome proliferator-activated receptor gamma,activation,activation,t,957,Telmisartan
CID000065999,5468,PPARG,9606.ENSP00000287820,Peroxisome proliferator-activated receptor gamma,activation,activation,t,997,Telmisartan
CID000071329,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,997,Dofetilide
CID000002284,9568,GABBR2,9606.ENSP00000259455,Gamma-aminobutyric acid type B receptor subunit 2,activation,activation,t,536,1134-47-0
CID000002284,9568,GABBR2,9606.ENSP00000259455,Gamma-aminobutyric acid type B receptor subunit 2,activation,activation,t,958,1134-47-0
CID000002284,9568,GABBR2,9606.ENSP00000259455,Gamma-aminobutyric acid type B receptor subunit 2,binding,activation,t,991,1134-47-0
CID000002153,136,ADORA2B,9606.ENSP00000304501,Adenosine receptor A2b,inhibition,inhibition,t,991,Theophylline
CID000002153,136,ADORA2B,9606.ENSP00000304501,Adenosine receptor A2b,binding,inhibition,t,958,Theophylline
CID000004158,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Methylphenidate
CID000004158,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,958,Methylphenidate
CID000004158,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,958,Methylphenidate
CID000004158,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,957,Methylphenidate
CID000004158,6531,SLC6A3,9606.ENSP00000270349,Sodium-dependent dopamine transporter,inhibition,inhibition,t,991,Methylphenidate
CID000005454,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,5591-45-7
CID000005454,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,5591-45-7
CID000004893,6581,SLC22A3,9606.ENSP00000275300,Solute carrier family 22 member 3,inhibition,inhibition,t,700,19216-56-9
CID000004893,6580,SLC22A1,9606.ENSP00000355930,Solute carrier family 22 member 1,inhibition,inhibition,t,700,19216-56-9
CID000004893,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,998,19216-56-9
CID000004893,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,19216-56-9
CID000004893,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,19216-56-9
CID000004893,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,inhibition,inhibition,t,998,19216-56-9
CID000004893,146,ADRA1D,9606.ENSP00000368766,Alpha-1D adrenergic receptor,binding,inhibition,t,800,19216-56-9
CID000004893,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,inhibition,inhibition,t,998,19216-56-9
CID000004893,147,ADRA1B,9606.ENSP00000306662,Alpha-1B adrenergic receptor,binding,inhibition,t,958,19216-56-9
CID000004893,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,19216-56-9
CID000004893,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,19216-56-9
CID000002995,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,inhibition,inhibition,t,998,Desipramine
CID000002995,1128,CHRM1,9606.ENSP00000306490,Muscarinic acetylcholine receptor M1,binding,inhibition,t,800,Desipramine
CID000002995,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,inhibition,inhibition,t,998,Desipramine
CID000002995,1133,CHRM5,9606.ENSP00000372750,Muscarinic acetylcholine receptor M5,binding,inhibition,t,800,Desipramine
CID000002995,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,inhibition,inhibition,t,998,Desipramine
CID000002995,1132,CHRM4,9606.ENSP00000409378,Muscarinic acetylcholine receptor M4,binding,inhibition,t,800,Desipramine
CID000002995,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,inhibition,inhibition,t,998,Desipramine
CID000002995,1131,CHRM3,9606.ENSP00000255380,Muscarinic acetylcholine receptor M3,binding,inhibition,t,800,Desipramine
CID000002995,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,activation,activation,t,536,Desipramine
CID000002995,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,activation,t,998,Desipramine
CID000002995,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,700,Desipramine
CID000002995,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,activation,activation,t,800,Desipramine
CID000002995,3757,KCNH2,9606.ENSP00000262186,Potassium voltage-gated channel subfamily H member 2,inhibition,inhibition,t,957,Desipramine
CID000002995,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,inhibition,inhibition,t,998,Desipramine
CID000002995,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Desipramine
CID000002995,6532,SLC6A4,9606.ENSP00000261707,Sodium-dependent serotonin transporter,inhibition,inhibition,t,998,Desipramine
CID000002995,6530,SLC6A2,9606.ENSP00000219833,Sodium-dependent noradrenaline transporter,inhibition,inhibition,t,998,Desipramine
CID000002995,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,activation,activation,t,536,Desipramine
CID000002995,3363,HTR7,9606.ENSP00000337949,5-hydroxytryptamine receptor 7,inhibition,inhibition,t,800,Desipramine
CID000002995,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,inhibition,inhibition,t,998,Desipramine
CID000002099,3359,HTR3A,9606.ENSP00000347754,5-hydroxytryptamine receptor 3A,inhibition,inhibition,t,958,122852-42-0
CID000004497,8856,NR1I2,9606.ENSP00000336528,Nuclear receptor subfamily 1 group I member 2,activation,activation,t,700,Nimodipine
CID000004748,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,inhibition,inhibition,t,991,Perphenazine
CID000004748,1813,DRD2,9606.ENSP00000354859,D(2) dopamine receptor,binding,inhibition,t,800,Perphenazine
CID000004748,3350,HTR1A,9606.ENSP00000316244,5-hydroxytryptamine receptor 1A,binding,inhibition,t,800,Perphenazine
CID000004748,3269,HRH1,9606.ENSP00000380247,Histamine H1 receptor,binding,inhibition,t,800,Perphenazine
CID000004748,152,ADRA2C,9606.ENSP00000386069,Alpha-2C adrenergic receptor,binding,inhibition,t,800,Perphenazine
CID000004748,150,ADRA2A,9606.ENSP00000280155,Alpha-2A adrenergic receptor,binding,inhibition,t,800,Perphenazine
CID000004748,148,ADRA1A,9606.ENSP00000369960,Alpha-1A adrenergic receptor,binding,inhibition,t,800,Perphenazine
CID000004748,3358,HTR2C,9606.ENSP00000276198,5-hydroxytryptamine receptor 2C,binding,inhibition,t,800,Perphenazine
CID000004748,1814,DRD3,9606.ENSP00000373169,D(3) dopamine receptor,binding,inhibition,t,800,Perphenazine
CID000005152,153,ADRB1,9606.ENSP00000358301,Beta-1 adrenergic receptor,binding,activation,t,958,Salmeterol
CID000005152,155,ADRB3,9606.ENSP00000343782,Beta-3 adrenergic receptor,binding,activation,t,958,Salmeterol
